These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11966644)

  • 1. The efficacy of terazosin for treating benign prostatic hyperplasia: a multicentre clinical trial.
    Miekos E; Trzepizur Z; Rózanski W; Boniecki R; Kusnierz J; Jablonowski Z; Zydek C
    BJU Int; 2002 May; 89(7):771-2. PubMed ID: 11966644
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of benign prostatic hyperplasia: terazosin or finasteride?].
    Trinkler FB
    Praxis (Bern 1994); 1997 Aug; 86(34):1305-6. PubMed ID: 9381019
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical comparison of selective and non-selective alpha 1A-adrenoreceptor antagonists in benign prostatic hyperplasia: studies on tamsulosin in a fixed dose and terazosin in increasing doses.
    Lee E; Lee C
    Br J Urol; 1997 Oct; 80(4):606-11. PubMed ID: 9352700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Terazosin in the treatment of benign prostatic hypertrophy].
    Andres M; De Cobelli O; Carmignani L; Musci R; Kocjancic E; Panizzutti M; Rocco F
    Arch Ital Urol Androl; 1995 Feb; 67(1):37-9. PubMed ID: 7538386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Side effects of terazosin in the treatment of symptomatic benign prostatic hyperplasia.
    McKiernan JM; Lowe FC
    South Med J; 1997 May; 90(5):509-13. PubMed ID: 9160069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of terazosin in patients with benign prostatic hyperplasia.
    Matzkin H; Soloway MS; Rangel MC; Laddu A
    Eur Urol; 1992; 21(2):126-30. PubMed ID: 1379921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Terazosine in the treatment of benign prostatic hypertrophy].
    Caine M
    J Urol (Paris); 1993; 99(6):311-3. PubMed ID: 7516376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of terazosin hydrochloride (Hytrin) in the treatment of patients with benign prostatic hyperplasia].
    Sivkov AV; Apolikhin OI; Medvedev AA
    Urol Nefrol (Mosk); 1997; (5):50-3. PubMed ID: 9412019
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety assessment of terazosin in the treatment of patients with symptomatic benign prostatic hyperplasia: a combined analysis.
    Lowe FC
    Urology; 1994 Jul; 44(1):46-51. PubMed ID: 7518981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terazosin, finasteride, or both in benign prostatic hyperplasia.
    Thien T; Lenders JW
    N Engl J Med; 1997 Jan; 336(4):294. PubMed ID: 9005318
    [No Abstract]   [Full Text] [Related]  

  • 11. Terazosin for benign prostatic hyperplasia.
    Med Lett Drugs Ther; 1994 Feb; 36(916):15-6. PubMed ID: 7508075
    [No Abstract]   [Full Text] [Related]  

  • 12. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.
    Lepor H; Williford WO; Barry MJ; Brawer MK; Dixon CM; Gormley G; Haakenson C; Machi M; Narayan P; Padley RJ
    N Engl J Med; 1996 Aug; 335(8):533-9. PubMed ID: 8684407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study.
    Yang Y; Zhao XF; Li HZ; Wang W; Zhang Y; Xiao H; Zhang X
    Chin Med J (Engl); 2007 Mar; 120(5):370-4. PubMed ID: 17376305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dose titration study evaluating terazosin, a selective, once-a-day alpha 1-blocker for the treatment of symptomatic benign prostatic hyperplasia.
    Lepor H; Knapp-Maloney G; Sunshine H
    J Urol; 1990 Dec; 144(6):1393-7; discussion 1397-8. PubMed ID: 1700152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A randomized comparative study assessing once versus twice a day treatment of benign prostatic hyperplasia with terazosin].
    Suzuki H; Ohnishi T; Ikemoto I; Ohishi Y; Suzuki Y; Yamazaki H
    Hinyokika Kiyo; 2001 Feb; 47(2):77-81. PubMed ID: 11280890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terazosin in the treatment of benign prostatic hyperplasia: a multicentre, placebo-controlled trial.
    Lloyd SN; Buckley JF; Chilton CP; Ibrahim I; Kaisary AV; Kirk D
    Br J Urol; 1992 Nov; 70 Suppl 1():17-21. PubMed ID: 1281727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of terazosin and tamsulosin for symptomatic benign prostatic hyperplasia in Japanese patients.
    Okada H; Kamidono S; Yoshioka T; Okuyama A; Ozono S; Hirao Y; Okajima E; Yamamoto K; Kishimoto T; Park Y; Kurita T
    BJU Int; 2000 Apr; 85(6):676-81. PubMed ID: 10759664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terazosin in the treatment of benign prostatic hyperplasia. Terazosin Benign Prostatic Hyperplasia Study Group.
    Brawer MK; Adams G; Epstein H
    Arch Fam Med; 1993 Sep; 2(9):929-35. PubMed ID: 7509243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind comparison of terazosin and tamsulosin on their differential effects on ambulatory blood pressure and nocturnal orthostatic stress testing.
    de Mey C; Michel MC; McEwen J; Moreland T
    Eur Urol; 1998; 33(5):481-8. PubMed ID: 9643668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of symptomatic benign prostatic hyperplasia with the once-daily alpha 1 blocker, terazosin.
    Woods AL
    Mil Med; 1992 Jul; 157(7):361-4. PubMed ID: 1382248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.